CSNK1A1 and neoplasm: CK1α regulates the activity of multiple proteins; for example, it negatively regulates TP53, a tumour-suppressor protein [66]; therefore, degradation of CK1α by lenalidomide restores TP53 and leads to clonal extinction of the del (5q) clone.